Atlas Trials

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Clinical trial NCT00429377 · COMPLETED

Trial details

NCT number
NCT00429377
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lupus Nephritis
Start date
2003-06-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.